References
1. Li Y., Qian W., Griffin B.B., Gao T., Chakravarti D., Bulum S., et al. HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma. Fertil Steril. 2020; 114 (5): 1085-96.
2. Vilos G.A., Allaire C., Laberge Ph.-Y. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015; 37 (2): 157-78. DOI: https://doi.org/10.1016/S1701-2163(15)30338-8
3. Zimmermann A., Bernuit D., Gerlinger C., Schaefers M., Geppert K. Prevalence, symptoms and management of uterine broids: an international Internet-based survey of 21,746 women. BMC Womens Health. 2012; 12: 6.
4. Moshesh M., Olshan A.F., et al. Examining the relationship between fibroids and dyspareunia among premenopausal women in the US. J Sex Med. 2014; 11 (3): 800-8.
5. Canadian Institute for Health Information, Statistics Canada. Health indicators. Ottawa: CIHI, 2010. URL: https://secure.cihi.ca/free_products/Healthindica-tors2010 (date of access November 10, 2014)
6. Blood-saving technologies in gynecological practice. Clinical protocol. Moscow, 2015. (in Russian)
7. Clark-Pearson D.L., Geller E.L. Complications of hysterectomy. Obstet. Gynecol. 2013; 121: 654-73.
8. Laughlin-Tommaso Sh.K., Jacoby V.L., Myers E.R. Disparities in fibroid incidence, prognosis, and management. Obstet Gynecol Clin North Am. 2017; 44 (1): 81-94.
9. Munro M.G., Critchley H.O.D., Fraser I.S. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018; 143 (3): 393-408.
10. Wegienka G., Baird D.D., Hertz-Picciotto I., et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol. 2003; 101 (3): 431-7.
11. Aguilar H.N., Mitchell B.F. Physiological pathways and molecular mechanisms regulating uterine contractility. Hum Reprod Update. 2010; 16 (6): 725-44.
12. Hickey M., Fraser I. Human uterine vascular structures in normal and diseased states. Microsc Res Tech. 2003; 60 (4): 377-89.
13. Parker W.H. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007; 87 (4): 725-36.
14. Tal R., Segar J.H. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update. 2014; 20 (2): 194-216.
15. Hapangama D.K., Bulmer J.N. Pathophysiology of heavy menstrual bleeding. Womens Health. 2016; 12 (1): 3-13.
16. Majak G.B., Lieng M., Qvigstad E. Clinical outcome after laparoscopic and open abdominal myomectomy. Gynecol Surg. 2012; 9: 231-4.
17. Radzinskiy V.E., Totchiev G.F. Uterine myoma: course on organ preservation. Newsletter. Moscow: Redaktsiya zhurnala StatusPraesens, 2014: 24 p. (in Russian)
18. Zepiridis L.I., Grimbizis G.F., Tarlatzis B.C. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 66-73.
19. Sundermann A.C., Velez Edwards D.R., Bray M.J., Jones S.H., Latham S.M., Hartmann K.E. Leiomyomas in pregnancy and spontaneous abortion: a systematic review and meta-analysis. Obstet Gynecol. 2017; 130 (5): 1065-72.
20. Uterine myoma: diagnosis, treatment and rehabilitation: clinical guidelines (treatment protocol). Moscow: Minzdrav RF, 2015. (in Russian)
21. Donnez J., Dolmans M.-M. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016; 22 (6): 665-86.
22. Sleiman Z., El Baba R., Garzon S., Khazaka A. The significant risk factors of intra-operative hemorrhage during laparoscopic myomectomy: a systematic review. Gynecol Minim Invasive Ther. 2019; 9 (1): 6-12.
23. Fujimoto A., Morimoto C., Hosokawa Y., Hasegawa A. Suturing method as a factor for uterine vascularity after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol. 2017; 211: 146-9. DOI: http://dx.doi.org/10.1016Zj.ejogrb.2017.02.027
24. Shin D.G., Yoo H.J., et al. Recurrence factors and reproductive outcomes of laparoscopic myomectomy and minilaparotomic myomectomy for uterine leiomyomas. Obstet Gynecol Sci. 2017; 60 (2): 193-9.
25. Yoo E.H., Lee P.I., Huh C.Y., Kim D.H., Lee B.S., Lee J.K., et al. Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Minim Invasive Gynecol. 2007; 14: 690-7.
26. Al-Mahrizi S., Tulandi T. Treatment of uterine broids for abnormal uterine bleeding: myomectomy and uterine artery embolization. Best Pract Res Clin Obstet Gynaecol. 2007; 21: 995-1005.
27. Taylor H.S. Fibroids: when should they be removed to improve in vitro fertilization success? Fertil Steril. 2018; 109 (5): 784-5.
28. Shue S., Radeva M., Falcone T. Fertility outcomes after myomectomy: relationship with number of fibroids removed. Fertil Steril. 2017; 108 (3): E208-E209.